Table 4.
Treatment group ID | Dose (mg/kg/dose) | Dose regimen | Number of data sets |
---|---|---|---|
Dlmn23 (a, b, c) | Control | No drug | 3 sets of average data |
Dlmn24 | 25 | IP bolus for two cycles of 5 consecutive days, with 16 days of rest between cycles | 1 set of average data |
Dlmn25 | 25 | IP bolus three times per week for 5 weeks | 1 set of average data |
Dlmn26 | 25 | IP bolus for two cycles of 14 consecutive days, with 7 days of rest between cycles | 1 set of average data |
Dlmn27 | 30 | IV bolus for two cycles of a dose given every 24 h for 5 consecutive doses with 3 days of rest between cycles | 1 set of average data |
Dlmn28 | 30 | IV bolus for two cycles of a dose given every 12 h for 5 consecutive doses with 5 1/2 days of rest between cycles | 1 set of average data |
Dlmn29 | 30 | IV bolus for two 2 cycles of a dose given every 2 h for 5 consecutive doses with 7 2/3 days of rest between cycles | 1 set of average data |
Dlmn30 | 60 | IV bolus on day 0 | 1 set of average data |
Dlmn31 | 60 | IV bolus on days 0 and 3 | 1 set of average data |
Dlmn32 | 60 | IV bolus for 5 consecutive days (days 0, 1, 2, 3, 4) | 1 set of average data |
Dlmn33 | 90 | IV bolus on day 0 | 1 set of average data |
The letters a, b, c, etc. are defined above